Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

10.0%

2 terminated out of 20 trials

Success Rate

88.2%

+1.7% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

3 of 15 completed with results

Key Signals

3 with results88% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (5)
P 1 (4)
P 2 (3)

Trial Status

Completed15
Recruiting3
Terminated2

Trial Success Rate

88.2%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT07476781Not ApplicableRecruiting

Exploring the Feasibility of Cerebrospinal Fluid (CSF) and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and Primary Central Nervous System (CNS) Tumours: A Pilot Study

NCT06680531Phase 1Completed

A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets

NCT04846764Not ApplicableCompleted

Rapid Declarative Neocortical Declarative Learning in Aging and Memory Diseases (ANéRAVIMM)

NCT02559752RecruitingPrimary

Computer-based Neurocognitive Assessment in Children With Central Nervous System Tumors Receiving Proton Beam Radiation Therapy

NCT07393074Not ApplicableRecruiting

PSYLIVER-PILOTE: Involvement of the Autonomic Nervous System in Hepatocellular Carcinoma (HCC)

NCT03268239Not ApplicableCompleted

Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions

NCT02652260Phase 2Completed

Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028)

NCT01541800Completed

Circulating microRNAs as Disease Markers in Pediatric Cancers

NCT03830762Phase 1Completed

Xanamem™ in Healthy Elderly Subjects

NCT05627986Completed

Sensorimotor Cortex Excitability in Shoulder Impingement Syndrome

NCT03430427CompletedPrimary

Brain Networks and Mobility Function: B-NET

NCT04644315Phase 2Terminated

A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

NCT02343718Phase 1Completed

Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours

NCT04014491Not ApplicableCompleted

The Effects of Exercise Training on Corticospinal System in Overhead Athletes With Shoulder Impingement Syndrome

NCT01517087Completed

Studying Motor Neuron Tests

NCT01006109TerminatedPrimary

Recording and Modulation of Neuronal Mechanisms During Operant Conditioning: a MEG Study

NCT01432288CompletedPrimary

Touch and Attention MRI Study

NCT01527006Phase 2CompletedPrimary

Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs

NCT01531920Phase 1CompletedPrimary

A Study in Healthy Subjects to Determine the Effects When Alcohol is Administered With Perampanel

NCT00067067CompletedPrimary

Investigating Endothelial Precursor Cells (EPCs)

Showing all 20 trials

Research Network

Activity Timeline